{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T02:51:50Z","timestamp":1773283910341,"version":"3.50.1"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2020,7,4]],"date-time":"2020-07-04T00:00:00Z","timestamp":1593820800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,7,4]],"date-time":"2020-07-04T00:00:00Z","timestamp":1593820800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Grants-in-Aid for Scientific Research","doi-asserted-by":"crossref","award":["17H04189"],"award-info":[{"award-number":["17H04189"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001691","name":"Grants-in-Aid for Scientific Research","doi-asserted-by":"crossref","award":["19K08726"],"award-info":[{"award-number":["19K08726"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP19ek0109231h0003"],"award-info":[{"award-number":["JP19ek0109231h0003"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP19ek0109231h0003"],"award-info":[{"award-number":["JP19ek0109231h0003"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["CEN Case Rep"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1007\/s13730-020-00503-8","type":"journal-article","created":{"date-parts":[[2020,7,4]],"date-time":"2020-07-04T04:26:16Z","timestamp":1593836776000},"page":"431-436","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["A case with somatic and germline mosaicism in COL4A5 detected by multiplex ligation-dependent probe amplification in X-linked Alport syndrome"],"prefix":"10.1007","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8106-9039","authenticated-orcid":false,"given":"Yuya","family":"Aoto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoo","family":"Kise","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichi","family":"Nakanishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"China","family":"Nagano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoko","family":"Horinouchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomohiko","family":"Yamamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinya","family":"Ishiko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nana","family":"Sakakibara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuko","family":"Shima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoya","family":"Morisada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazumoto","family":"Iijima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kandai","family":"Nozu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,7,4]]},"reference":[{"issue":"5","key":"503_CR1","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1681\/ASN.2009070784","volume":"21","author":"MR Bekheirnia","year":"2010","unstructured":"Bekheirnia MR, Reed B, Gregory MC, McFann K, Shamshirsaz AA, Masoumi A, et al. Genotype-phenotype correlation in X-linked Alport syndrome. J Am Soc Nephrol. 2010;21(5):876\u201383. https:\/\/doi.org\/10.1681\/ASN.2009070784.","journal-title":"J Am Soc Nephrol"},{"issue":"7","key":"503_CR2","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1093\/ndt\/17.7.1218","volume":"17","author":"O Gross","year":"2002","unstructured":"Gross O, Netzer KO, Lambrecht R, Seibold S, Weber M. Meta-analysis of genotype-phenotype correlation in X-linked Alport syndrome: impact on clinical counselling. Nephrol Dial Transplant. 2002;17(7):1218\u201327.","journal-title":"Nephrol Dial Transplant"},{"issue":"4","key":"503_CR3","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1681\/ASN.V114649","volume":"11","author":"JP Jais","year":"2000","unstructured":"Jais JP, Knebelmann B, Giatras I, De Marchi M, Rizzoni G, Renieri A, et al. X-linked Alport syndrome: natural history in 195 families and genotype- phenotype correlations in males. J Am Soc Nephrol. 2000;11(4):649\u201357.","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"503_CR4","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1007\/s10157-018-1629-4","volume":"23","author":"K Nozu","year":"2019","unstructured":"Nozu K, Nakanishi K, Abe Y, Udagawa T, Okada S, Okamoto T, et al. A review of clinical characteristics and genetic backgrounds in Alport syndrome. Clin Exp Nephrol. 2019;23(2):158\u201368. https:\/\/doi.org\/10.1007\/s10157-018-1629-4.","journal-title":"Clin Exp Nephrol"},{"issue":"10","key":"503_CR5","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.1097\/01.ASN.0000090034.71205.74","volume":"14","author":"JP Jais","year":"2003","unstructured":"Jais JP, Knebelmann B, Giatras I, De Marchi M, Rizzoni G, Renieri A, et al. X-linked Alport syndrome: natural history and genotype-phenotype correlations in girls and women belonging to 195 families: a \"European Community Alport syndrome concerted action\" study. J Am Soc Nephrol. 2003;14(10):2603\u201310.","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"503_CR6","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1016\/j.ekir.2017.04.011","volume":"2","author":"T Yamamura","year":"2017","unstructured":"Yamamura T, Nozu K, Fu XJ, Nozu Y, Ye MJ, Shono A, et al. Natural history and genotype-phenotype correlation in female X-linked Alport syndrome. Kidney Int Rep. 2017;2(5):850\u20135. https:\/\/doi.org\/10.1016\/j.ekir.2017.04.011.","journal-title":"Kidney Int Rep"},{"issue":"2","key":"503_CR7","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/j.gene.2013.05.045","volume":"526","author":"S Beicht","year":"2013","unstructured":"Beicht S, Strobl-Wildemann G, Rath S, Wachter O, Alberer M, Kaminsky E, et al. Next generation sequencing as a useful tool in the diagnostics of mosaicism in Alport syndrome. Gene. 2013;526(2):474\u20137. https:\/\/doi.org\/10.1016\/j.gene.2013.05.045.","journal-title":"Gene"},{"issue":"7","key":"503_CR8","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1016\/j.ekir.2019.03.005","volume":"4","author":"L Bu","year":"2019","unstructured":"Bu L, Chen J, Nelson AC, Katz A, Kashtan CE, Kim Y, et al. Somatic mosaicism in a male patient with X-linked Alport syndrome. Kidney Int Rep. 2019;4(7):1031\u20135. https:\/\/doi.org\/10.1016\/j.ekir.2019.03.005.","journal-title":"Kidney Int Rep"},{"issue":"3","key":"503_CR9","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/ejhg.2015.113","volume":"24","author":"XJ Fu","year":"2016","unstructured":"Fu XJ, Nozu K, Kaito H, Ninchoji T, Morisada N, Nakanishi K, et al. Somatic mosaicism and variant frequency detected by next-generation sequencing in X-linked Alport syndrome. Eur J Hum Genet. 2016;24(3):387\u201391. https:\/\/doi.org\/10.1038\/ejhg.2015.113.","journal-title":"Eur J Hum Genet"},{"issue":"8","key":"503_CR10","doi-asserted-by":"publisher","first-page":"2525","DOI":"10.1093\/ndt\/gfn005","volume":"23","author":"RP Krol","year":"2008","unstructured":"Krol RP, Nozu K, Nakanishi K, Iijima K, Takeshima Y, Fu XJ, et al. Somatic mosaicism for a mutation of the COL4A5 gene is a cause of mild phenotype male Alport syndrome. Nephrol Dial Transplant. 2008;23(8):2525\u201330. https:\/\/doi.org\/10.1093\/ndt\/gfn005.","journal-title":"Nephrol Dial Transplant"},{"issue":"3","key":"503_CR11","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1136\/jmg.37.3.238","volume":"37","author":"KE Plant","year":"2000","unstructured":"Plant KE, Boye E, Green PM, Vetrie D, Flinter FA. Somatic mosaicism associated with a mild Alport syndrome phenotype. J Med Genet. 2000;37(3):238\u20139. https:\/\/doi.org\/10.1136\/jmg.37.3.238.","journal-title":"J Med Genet"},{"issue":"5","key":"503_CR12","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1007\/s10157-016-1352-y","volume":"21","author":"K Yokota","year":"2017","unstructured":"Yokota K, Nozu K, Minamikawa S, Yamamura T, Nakanishi K, Kaneda H, et al. Female X-linked Alport syndrome with somatic mosaicism. Clin Exp Nephrol. 2017;21(5):877\u201383. https:\/\/doi.org\/10.1007\/s10157-016-1352-y.","journal-title":"Clin Exp Nephrol"},{"issue":"9","key":"503_CR13","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1007\/s00467-009-1122-0","volume":"24","author":"K Nozu","year":"2009","unstructured":"Nozu K, Krol RP, Nakanishi K, Yoshikawa N, Nozu Y, Ohtsuka Y, et al. Detection by multiplex ligation-dependent probe amplification of large deletion mutations in the COL4A5 gene in female patients with Alport syndrome. Pediatr Nephrol. 2009;24(9):1773\u20134. https:\/\/doi.org\/10.1007\/s00467-009-1122-0.","journal-title":"Pediatr Nephrol"},{"issue":"4","key":"503_CR14","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1007\/s10157-018-1534-x","volume":"22","author":"C Nagano","year":"2018","unstructured":"Nagano C, Nozu K, Morisada N, Yazawa M, Ichikawa D, Numasawa K, et al. Detection of copy number variations by pair analysis using next-generation sequencing data in inherited kidney diseases. Clin Exp Nephrol. 2018;22(4):881\u20138. https:\/\/doi.org\/10.1007\/s10157-018-1534-x.","journal-title":"Clin Exp Nephrol"},{"issue":"9","key":"503_CR15","doi-asserted-by":"publisher","first-page":"e883","DOI":"10.1002\/mgg3.883","volume":"7","author":"T Yamamura","year":"2019","unstructured":"Yamamura T, Nozu K, Minamikawa S, Horinouchi T, Sakakibara N, Nagano C, et al. Comparison between conventional and comprehensive sequencing approaches for genetic diagnosis of Alport syndrome. Mol Genet Genomic Med. 2019;7(9):e883. https:\/\/doi.org\/10.1002\/mgg3.883.","journal-title":"Mol Genet Genomic Med"},{"issue":"4","key":"503_CR16","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1002\/ajmg.c.31421","volume":"166C","author":"NB Spinner","year":"2014","unstructured":"Spinner NB, Conlin LK. Mosaicism and clinical genetics. Am J Med Genet C Semin Med Genet. 2014;166C(4):397\u2013405. https:\/\/doi.org\/10.1002\/ajmg.c.31421.","journal-title":"Am J Med Genet C Semin Med Genet"},{"issue":"5","key":"503_CR17","doi-asserted-by":"publisher","first-page":"e647","DOI":"10.1002\/mgg3.647","volume":"7","author":"Y Zhang","year":"2019","unstructured":"Zhang Y, Ding J, Zhang H, Yao Y, Xiao H, Wang S, et al. Effect of heterozygous pathogenic COL4A3 or COL4A4 variants on patients with X-linked Alport syndrome. Mol Genet Genomic Med. 2019;7(5):e647. https:\/\/doi.org\/10.1002\/mgg3.647.","journal-title":"Mol Genet Genomic Med"},{"issue":"1","key":"503_CR18","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1111\/cge.12919","volume":"92","author":"C Fallerini","year":"2017","unstructured":"Fallerini C, Baldassarri M, Trevisson E, Morbidoni V, La Manna A, Lazzarin R, et al. Alport syndrome: impact of digenic inheritance in patients management. Clin Genet. 2017;92(1):34\u201344. https:\/\/doi.org\/10.1111\/cge.12919.","journal-title":"Clin Genet"},{"issue":"3","key":"503_CR19","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1136\/jmedgenet-2014-102822","volume":"52","author":"MA Mencarelli","year":"2015","unstructured":"Mencarelli MA, Heidet L, Storey H, van Geel M, Knebelmann B, Fallerini C, et al. Evidence of digenic inheritance in Alport syndrome. J Med Genet. 2015;52(3):163\u201374. https:\/\/doi.org\/10.1136\/jmedgenet-2014-102822.","journal-title":"J Med Genet"},{"issue":"4","key":"503_CR20","first-page":"736","volume":"57","author":"K Nakanishi","year":"2015","unstructured":"Nakanishi K, Yoshikawa N. Alport syndrome. Nihon Jinzo Gakkai Shi. 2015;57(4):736\u201342.","journal-title":"Nihon Jinzo Gakkai Shi"}],"container-title":["CEN Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13730-020-00503-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13730-020-00503-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13730-020-00503-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,3]],"date-time":"2021-07-03T23:39:32Z","timestamp":1625355572000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13730-020-00503-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,4]]},"references-count":20,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["503"],"URL":"https:\/\/doi.org\/10.1007\/s13730-020-00503-8","relation":{},"ISSN":["2192-4449"],"issn-type":[{"value":"2192-4449","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,4]]},"assertion":[{"value":"10 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 June 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Kazumoto Iijima has received grant support from Daiichi Sankyo Co., Ltd., as well as consulting fees from Takeda Pharmaceutical Company and Kyowa Hakko Kirin Co., Ltd. Kandai Nozu has received lecture fees from Novartis Pharmaceuticals Corporation. Kazumoto Iijima and Kandai Nozu have filed a patent application regarding the development of antisense nucleotides for exon-skipping therapy in Alport syndrome.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in this study involving human participants were in accordance with the ethical standards of the institutional research committee at Kobe University and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all of the participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}